Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Proportion of SARS-CoV-2 Infections That Are Asymptomatic
Daniel P. Oran, Eric J. Topol
Annals of Internal Medicine (2021) Vol. 174, Iss. 5, pp. 655-662
Open Access | Times Cited: 521

Showing 26-50 of 521 citing articles:

Ambient Air Pollution in Relation to SARS-CoV-2 Infection, Antibody Response, and COVID-19 Disease: A Cohort Study in Catalonia, Spain (COVICAT Study)
Manolis Kogevinas, Gemma Castaño‐Vinyals, Marianna Karachaliou, et al.
Environmental Health Perspectives (2021) Vol. 129, Iss. 11
Open Access | Times Cited: 72
SARS-CoV-2 new variants: Characteristic features and impact on the efficacy of different vaccines
Abbas Khan, Taimoor Ashraf Khan, Shughla Ali, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 143, pp. 112176-112176
Open Access | Times Cited: 71
Role of Gut Microbiome in COVID-19: An Insight Into Pathogenesis and Therapeutic Potential
Ikram Hussain, Gabriel Liu Yuan Cher, Muhammad Abbas Abid, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 68
COVID-19-associated psychosis: A systematic review of case reports
Colin M. Smith, Elizabeth B. Gilbert, Paul A. Riordan, et al.
General Hospital Psychiatry (2021) Vol. 73, pp. 84-100
Open Access | Times Cited: 64
Characterization of the Human Oropharyngeal Microbiomes in SARS‐CoV‐2 Infection and Recovery Patients
Ming Gao, Haiyu Wang, Hong Luo, et al.
Advanced Science (2021) Vol. 8, Iss. 20
Open Access | Times Cited: 63
COVID-19 and chronic fatigue syndrome: An endocrine perspective
Rashika Bansal, Sriram Gubbi, Christian A. Koch
Journal of Clinical & Translational Endocrinology (2021) Vol. 27, pp. 100284-100284
Open Access | Times Cited: 60
Improved Strategies for CRISPR-Cas12-based Nucleic Acids Detection
Miao Qiu, Xiaoming Zhou, Lei Liu
Journal of Analysis and Testing (2022) Vol. 6, Iss. 1, pp. 44-52
Open Access | Times Cited: 57
Predicting the protective humoral response to a SARS-CoV-2 mRNA vaccine
Silvia Meschi, Giulia Matusali, Francesca Colavita, et al.
Clinical Chemistry and Laboratory Medicine (CCLM) (2021) Vol. 59, Iss. 12, pp. 2010-2018
Open Access | Times Cited: 56
Acute Kidney Injury in COVID-19
Marta Głowacka, Sara Lipka, Ewelina Młynarska, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 15, pp. 8081-8081
Open Access | Times Cited: 55
Autoimmune Encephalitis After SARS-CoV-2 Infection
Cristina Valencia Sánchez, Elitza S. Theel, Matthew J. Binnicker, et al.
Neurology (2021) Vol. 97, Iss. 23
Open Access | Times Cited: 55
Characterising within-hospital SARS-CoV-2 transmission events using epidemiological and viral genomic data across two pandemic waves
Benjamin B. Lindsey, Christian Julián Villabona‐Arenas, Finlay Campbell, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 54
Comparative Assessment of Filtration- and Precipitation-Based Methods for the Concentration of SARS-CoV-2 and Other Viruses from Wastewater
Kata Farkas, Cameron Pellett, Natasha Alex-Sanders, et al.
Microbiology Spectrum (2022) Vol. 10, Iss. 4
Open Access | Times Cited: 43
Acute and post-acute COVID-19 presentations in athletes: a systematic review and meta-analysis
Ítalo Ribeiro Lemes, Fabiana Infante Smaira, Willian J. D. Ribeiro, et al.
British Journal of Sports Medicine (2022) Vol. 56, Iss. 16, pp. 941-947
Open Access | Times Cited: 38
Biological Properties of SARS-CoV-2 Variants: Epidemiological Impact and Clinical Consequences
Reem Hoteit, Hadi M. Yassine
Vaccines (2022) Vol. 10, Iss. 6, pp. 919-919
Open Access | Times Cited: 38
T cell immune memory after covid-19 and vaccination
Lulu Wang, Alexander R. Nicols, Lance Turtle, et al.
BMJ Medicine (2023) Vol. 2, Iss. 1, pp. e000468-e000468
Open Access | Times Cited: 27
Effectiveness of the 2023–2024 Formulation of the Coronavirus Disease 2019 Messenger RNA Vaccine
Nabin K. Shrestha, Patrick C. Burke, Amy S. Nowacki, et al.
Clinical Infectious Diseases (2024) Vol. 79, Iss. 2, pp. 405-411
Closed Access | Times Cited: 12
The impact of COVID-19 on surgical procedures in Japan: analysis of data from the National Clinical Database
Norihiko Ikeda, Hiroyuki Yamamoto, Akinobu Taketomi, et al.
Surgery Today (2021) Vol. 52, Iss. 1, pp. 22-35
Open Access | Times Cited: 54
The Sexual Long COVID (SLC): Erectile Dysfunction as a Biomarker of Systemic Complications for COVID-19 Long Haulers
Andrea Sansone, Daniele Mollaioli, Erika Limoncin, et al.
Sexual Medicine Reviews (2021) Vol. 10, Iss. 2, pp. 271-285
Open Access | Times Cited: 53
Transmission of SARS-CoV-2 After COVID-19 Screening and Mitigation Measures for Primary School Children Attending School in Liège, Belgium
Christelle Meuris, Cécile Kremer, Anton Geerinck, et al.
JAMA Network Open (2021) Vol. 4, Iss. 10, pp. e2128757-e2128757
Open Access | Times Cited: 52
Comparison of Estimated Effectiveness of Case-Based and Population-Based Interventions on COVID-19 Containment in Taiwan
Ta-Chou Ng, Hao‐Yuan Cheng, Hsiao‐Han Chang, et al.
JAMA Internal Medicine (2021) Vol. 181, Iss. 7, pp. 913-913
Open Access | Times Cited: 51
Predominant airborne transmission and insignificant fomite transmission of SARS-CoV-2 in a two-bus COVID-19 outbreak originating from the same pre-symptomatic index case
Pan Cheng, Kaiwei Luo, Shenglan Xiao, et al.
Journal of Hazardous Materials (2021) Vol. 425, pp. 128051-128051
Open Access | Times Cited: 50
High Prevalence of Anti–Severe Acute Respiratory Syndrome Coronavirus 2 (Anti–SARS-CoV-2) Antibodies After the First Wave of Coronavirus Disease 2019 (COVID-19) in Kinshasa, Democratic Republic of the Congo: Results of a Cross-sectional Household-Based Survey
Antoine Nkuba-Ndaye, Sheila Makiala‐Mandanda, Emilande Guichet, et al.
Clinical Infectious Diseases (2021) Vol. 74, Iss. 5, pp. 882-890
Open Access | Times Cited: 48
Prevalence and factors associated with SARS-CoV-2 seropositivity in the Spanish HIV Research Network Cohort
Juan Berenguer, Cristina Díez, María Martin‐Vicente, et al.
Clinical Microbiology and Infection (2021) Vol. 27, Iss. 11, pp. 1678-1684
Open Access | Times Cited: 43
Antibody response to SARS-CoV-2 for more than one year − kinetics and persistence of detection are predominantly determined by avidity progression and test design
Heinrich Scheiblauer, C. Micha Nübling, Timo Wolf, et al.
Journal of Clinical Virology (2021) Vol. 146, pp. 105052-105052
Open Access | Times Cited: 43
COVID-19 severity: Studying the clinical and demographic risk factors for adverse outcomes
Naila Shoaib, Naila Noureen, Rimsha Munir, et al.
PLoS ONE (2021) Vol. 16, Iss. 8, pp. e0255999-e0255999
Open Access | Times Cited: 42

Scroll to top